Clinical Trial Update: An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis" [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Fluorothiazinone (300 mg) in adults with chronic bacterial cystitis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii Infection
• Bacterial Cystitis
• Enterococcus Faecalis Infection
• Escherichia Coli Infection
• Klebsiella Pneumoniae Infection
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Fluorothiazinone (Fluorothiazinone)

Snippet

Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Conditions: P. Aeruginosa, Baumannii | Phase 3 | Status: NOT_YET_RECRUITING